Free Trial

enVVeno Medical (NVNO) Competitors

enVVeno Medical logo
$2.85 -0.06 (-2.06%)
(As of 10:47 AM ET)

NVNO vs. NYXH, ARAY, KRMD, SKIN, OBIO, SGHT, INFU, BWAY, PDEX, and NVRO

Should you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include Nyxoah (NYXH), Accuray (ARAY), KORU Medical Systems (KRMD), Beauty Health (SKIN), Orchestra BioMed (OBIO), Sight Sciences (SGHT), InfuSystem (INFU), BrainsWay (BWAY), Pro-Dex (PDEX), and Nevro (NVRO). These companies are all part of the "surgical & medical instruments" industry.

enVVeno Medical vs.

Nyxoah (NASDAQ:NYXH) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, community ranking, profitability, risk, media sentiment, earnings and valuation.

34.7% of enVVeno Medical shares are held by institutional investors. 17.1% of Nyxoah shares are held by insiders. Comparatively, 16.0% of enVVeno Medical shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

enVVeno Medical has a net margin of 0.00% compared to Nyxoah's net margin of -1,043.93%. enVVeno Medical's return on equity of -48.72% beat Nyxoah's return on equity.

Company Net Margins Return on Equity Return on Assets
Nyxoah-1,043.93% -51.68% -40.11%
enVVeno Medical N/A -48.72%-45.96%

enVVeno Medical received 118 more outperform votes than Nyxoah when rated by MarketBeat users. However, 71.70% of users gave Nyxoah an outperform vote while only 62.65% of users gave enVVeno Medical an outperform vote.

CompanyUnderperformOutperform
NyxoahOutperform Votes
38
71.70%
Underperform Votes
15
28.30%
enVVeno MedicalOutperform Votes
156
62.65%
Underperform Votes
93
37.35%

Nyxoah has a beta of 1.35, meaning that its stock price is 35% more volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.22, meaning that its stock price is 22% more volatile than the S&P 500.

Nyxoah presently has a consensus price target of $17.00, indicating a potential upside of 110.92%. Given Nyxoah's stronger consensus rating and higher probable upside, analysts clearly believe Nyxoah is more favorable than enVVeno Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nyxoah
0 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
3.00
enVVeno Medical
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

enVVeno Medical has lower revenue, but higher earnings than Nyxoah. Nyxoah is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nyxoah$5.08M39.55-$46.77M-$1.87-4.31
enVVeno MedicalN/AN/A-$23.52M-$1.29-2.22

In the previous week, enVVeno Medical had 1 more articles in the media than Nyxoah. MarketBeat recorded 3 mentions for enVVeno Medical and 2 mentions for Nyxoah. enVVeno Medical's average media sentiment score of 0.14 beat Nyxoah's score of 0.00 indicating that enVVeno Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nyxoah
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
enVVeno Medical
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

enVVeno Medical beats Nyxoah on 9 of the 17 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVNO vs. The Competition

MetricenVVeno MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$51.03M$4.33B$5.20B$9.14B
Dividend YieldN/A44.59%5.12%4.29%
P/E Ratio-2.2624.5287.0717.11
Price / SalesN/A52.161,159.67122.74
Price / CashN/A43.4043.2337.85
Price / Book0.847.074.804.78
Net Income-$23.52M$13.64M$120.46M$225.43M
7 Day Performance4.30%-0.90%-0.91%-0.82%
1 Month Performance-14.66%-1.55%14.91%1.02%
1 Year Performance-40.61%38.74%29.59%15.72%

enVVeno Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVNO
enVVeno Medical
2.252 of 5 stars
$2.85
-2.1%
N/A-40.6%$49.98MN/A-2.2119News Coverage
Gap Up
NYXH
Nyxoah
1.7946 of 5 stars
$8.00
-0.1%
$17.00
+112.5%
+68.4%$199.52M$5.08M-4.28146
ARAY
Accuray
4.5905 of 5 stars
$1.87
+1.1%
$9.00
+381.3%
-34.8%$188.06M$444.20M-11.00987
KRMD
KORU Medical Systems
1.1766 of 5 stars
$3.95
-1.7%
$4.13
+4.4%
+66.0%$181.06M$31.99M-15.8080Upcoming Earnings
SKIN
Beauty Health
1.8216 of 5 stars
$1.44
-1.4%
$2.55
+77.1%
-56.2%$178.74M$347.62M-3.431,030
OBIO
Orchestra BioMed
2.0672 of 5 stars
$4.69
-4.7%
$15.75
+235.8%
-50.6%$178.29M$2.65M-2.9156Positive News
SGHT
Sight Sciences
3.5252 of 5 stars
$3.51
-1.7%
$5.12
+45.9%
-3.6%$178.15M$79.54M-3.44210
INFU
InfuSystem
1.3504 of 5 stars
$8.15
-1.9%
$13.00
+59.5%
N/A$173.30M$132.78M135.86499
BWAY
BrainsWay
3.9774 of 5 stars
$9.15
-1.0%
$13.17
+43.9%
+29.4%$172.14M$38.63M91.51120Analyst Forecast
News Coverage
PDEX
Pro-Dex
2.6291 of 5 stars
$45.90
-5.8%
$52.00
+13.3%
+166.7%$158.86M$56.80M29.81140
NVRO
Nevro
2.1843 of 5 stars
$3.77
-0.5%
$6.30
+67.1%
-82.5%$141.27M$419.15M-1.991,215

Related Companies and Tools


This page (NASDAQ:NVNO) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners